US 8709443
Reovirus for the treatment of cellular proliferative disorders
granted A61KA61K35/765A61K9/0019
Quick answer
US patent 8709443 (Reovirus for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K35/765, A61K9/0019, A61P, A61P31/12